Bunge Global (NYSE:BG – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 9.250- for the period, compared to the consensus estimate of 9.430. The company issued revenue guidance of -. Bunge Global also updated its FY24 guidance to at least $9.25 EPS.
Analysts Set New Price Targets
Separately, Citigroup downgraded Bunge Global from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $125.00 to $114.00 in a research report on Thursday, August 1st. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $118.00.
Check Out Our Latest Analysis on Bunge Global
Bunge Global Stock Performance
Bunge Global (NYSE:BG – Get Free Report) last issued its earnings results on Wednesday, October 30th. The basic materials company reported $2.29 earnings per share for the quarter, beating analysts’ consensus estimates of $2.18 by $0.11. The firm had revenue of $12.91 billion for the quarter, compared to analysts’ expectations of $12.68 billion. Bunge Global had a return on equity of 13.71% and a net margin of 2.11%. Analysts expect that Bunge Global will post 9.35 EPS for the current year.
Bunge Global Company Profile
Bunge Global SA operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains comprising wheat and corn; and processes oilseeds into vegetable oils and protein meals.
Recommended Stories
- Five stocks we like better than Bunge Global
- Stock Analyst Ratings and Canadian Analyst Ratings
- Battle of the Retailers: Who Comes Out on Top?
- ETF Screener: Uses and Step-by-Step Guide
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What is a Special Dividend?
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Bunge Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunge Global and related companies with MarketBeat.com's FREE daily email newsletter.